Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013
Crossref DOI link: https://doi.org/10.1007/s00125-016-3971-y
Published Online: 2016-05-18
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Norhammar, Anna
Bodegård, Johan
Nyström, Thomas
Thuresson, Marcus
Eriksson, Jan W.
Nathanson, David
Funding for this research was provided by:
This study was sponsored by AstraZeneca
Text and Data Mining valid from 2016-05-18